Navigation Links
Multiple Studies Presented at San Antonio Breast Cancer Symposium Reinforce Clinical Utility of Oncotype DX(R)
Date:12/17/2007

Presentations Provide New Insights into Treatment Impact, Node-Positive

Breast Cancer, Measuring ER/PR Scores

REDWOOD CITY, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple studies reinforcing the clinical utility of the company's Oncotype DX(R), a multi-gene expression test to predict the likelihood of recurrence and the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients. This research was presented at the 30th Annual San Antonio Breast Cancer Symposium, December 13-15.

"The extensive body of research on Oncotype DX, including data presented in San Antonio this week, along with its recent inclusion in ASCO treatment guidelines, supports the use of Oncotype DX in treatment planning for women with early-stage estrogen receptor-positive breast cancer," said Lori J. Goldstein, M.D., Director of the Breast Evaluation Center at Fox Chase Cancer Center in Philadelphia, Pennsylvania, and author of two Oncotype DX studies.

Eight studies presented at the San Antonio Breast Cancer Symposium evaluated Oncotype DX, including its use in estrogen receptor-positive, node- positive breast cancer; the test's impact on treatment selection and patient satisfaction; reporting of quantitative ER and PR scores within the Oncotype DX report; and a comparison between the Oncotype DX Recurrence Score(TM) and Adjuvant Online, among other presentations.

Positive Results in Node-Positive Disease

* An oral presentation by the Southwest Oncology Group (SWOG) on

Thursday, December 13 reported positive results for the Oncotype DX

Recurrence Score result in early-stage estrogen receptor
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
3. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
4. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
5. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
6. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
7. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
8. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
9. Pharmacopeia Announces Positive Results from Phase 1 Multiple Ascending Dose Study of PS433540 (DARA)
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014 InfinityQS ... and Manufacturing Intelligence , today announces Infusion ... The event will be held Oct. 9-10, 2014, ... is designed to showcase the necessity for implementing ... metrics and Manufacturing Intelligence to gain insight into ...
(Date:8/21/2014)... 21, 2014 CVS Caremark Corporation (NYSE: ... Yields and consideration payable in connection with its previously announced ... 2014 for (1) any and all of its 6.250% Senior ... up to a maximum amount of its 6.125% Senior Notes ... Notes due 2017 (collectively, the "Maximum Tender Offer Notes" and ...
(Date:8/21/2014)... TORONTO , Aug. 21, 2014 /CNW/ - Bedrocan ... appointed three independent members to its Board of ... care experience of the company, a leading licensed ... . Internationally, Bedrocan has 13 years, experience ... patients in seven countries, including Canada. ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
(Date:8/22/2014)... Dealing with a drug or alcohol addiction is ... a child. Adolescent substance abuse has been an important issue ... a new helpline is now providing a valuable resource for ... something like a teen drug addiction . , ... a positive impact in the community. By calling (513) 318-1603, ...
(Date:8/22/2014)... August 22, 2014 The rising numbers of ... Akron, OH. Over the years, countless lives have been lost ... a difference in the community a new helpline was established ... teens in Northeast Ohio who are seeking to overcome their ... Akron helpline at (300) 400-2616, parents and their teens can ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Aid in ... released a statement today regarding a recent bill ... Representative Samuel Pagdilao, a current legislator and retired police ... treatment for drug related offenders, rather than imprisonment. Aid ... of a forward-thinking solution for the drug addiction epidemic. ...
(Date:8/22/2014)... Carolina Senior Living Apartments, owned and ... ), recently opened 30 spacious one-bedroom affordable residential ... resources in Lexington, NC. Each unit is equipped ... controlled heating and cooling system, and secured entry. ... consists of a three-story building with an elevator ...
(Date:8/21/2014)... August 22, 2014 Os-Monitor.com, an ... unveiled its new employee monitoring software collection ( ... has also announced that all these high end ... , With the tendency of improving productivity, the ... efficiency than before. Thus, employee and network monitoring ...
Breaking Medicine News(10 mins):Health News:Cincinnati’s New Troubled Teen Helpline is Making a Difference in the Community 2Health News:Troubled Teens in Akron, OH Can Receive Assistance from New Helpline for Addiction Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 2Health News:Proposed Legislature in the Philippines Highlights the Need for Rehabilitation, Not Incarceration, for Drug Users, Says Aid in Recovery 3Health News:United Church Homes and Services Announce New Affordable Housing Community for Seniors 2Health News:New Employee Monitoring Software Collection Unveiled By Os-Monitor.com 2
... the devil grabs it while the angels are debating the ... ,Mobile technology, specifically the use of cell phones, has become ... and has permanently changed our perception about life and communication. ... with the device, which has been taken so much for ...
... time men got their share from women in the inheritance of ... of breast and ovarian cancers also significantly increases the danger of ... ,Genetic mechanisms have been examined in the familial inheritance ... gene is associated with increased risk in women who have a ...
... routine practice to prescribe drugs called immunosuppressant to transplant ... The medical community has only been interested in worrying ... the other side of the coin, there seems to ... found out that the immunosuppressive drug mycophenolate mofetil, used ...
... countries to intensify surveillance and prepare for emergencies due to ... to Europe, Middle East and Africa.// Though the initial risk ... of the virus may mutate and may cause infections to ... and requires immediate control and elimination of the virus because ...
... claim victims in India's most populous state of Uttar ... since the disease broke out a month ago. // ... Gorakhpur, where a nodal treatment centre was established to ... districts, and assured all possible help from the central ...
... methods for a stress free and healthy life will ... Living foundation and the Krasnoyarsk State Medical Academy have ... and community healthcare initiatives.// The MoU was signed during ... ,Under the agreement, the academy will join hands with ...
Cached Medicine News:Health News:An Under Estimation Of The Radiation Hazard With The Use Of Mobile Phones 2Health News:An Under Estimation Of The Radiation Hazard With The Use Of Mobile Phones 3Health News:Genes responsible for cancer in women associated with increased cancer risk in men 2
Cannulated Interference Screws...
BioScrew® Bio-Absorbable Interference Screws and Delivery System Clinically equivalent to metal interference screws....
... Cannulated Interference Screws. ... strength and graft selection ... easily without deformation, and ... full threaded atraumatic tissue ...
Cannulated Interference Screws...
Medicine Products: